Publicaciones en colaboración con investigadores/as de Institut d'Investigacions Biomèdiques August Pi i Sunyer (24)

2024

  1. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

    Journal of Psychiatric Research, Vol. 172, pp. 334-339

2023

  1. The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice

    Neurobiology of Disease, Vol. 184

2022

  1. Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages

    Frontiers in Molecular Biosciences, Vol. 9

  2. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain

    Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941

  3. New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases

    Frontiers in Aging Neuroscience, Vol. 13

2020

  1. Acute effects of a session of electroconvulsive therapy on brain-derived neurotrophic factor plasma levels

    Revista de Psiquiatria y Salud Mental

  2. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)

    Targeted Oncology, Vol. 15, Núm. 5, pp. 613-622

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

  2. Effects of electroconvulsive therapy in the systemic inflammatory balance of patients with severe mental disorder

    Psychiatry and Clinical Neurosciences, Vol. 73, Núm. 10, pp. 628-635

2016

  1. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: Role of 5-HT1A receptors

    Neuropharmacology, Vol. 103, pp. 16-26

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 41, Núm. 3, pp. E46-E55

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  5. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration

    Molecular Psychiatry, Vol. 21, Núm. 3, pp. 328-338

2015

  1. Desarrollo profesional en investigación traslacional en neurociencias y salud mental: educación y formación dentro del Centro de Investigación Biomédica en Red en Salud Mental

    Revista de Psiquiatria y Salud Mental, Vol. 8, Núm. 2, pp. 65-74

2014

  1. Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study

    Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29

  2. Purinergic receptors in ocular inflammation

    Mediators of Inflammation, Vol. 2014

2013

  1. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis.

    Translational psychiatry, Vol. 3